Skip to Main Content
Recruiting

FARSC: Remote Sample Collection for ALL Survivors

About this study 

Children who survive acute lymphoblastic leukemia (ALL) may have health problems later in life. Cancer treatment, stress, and conditions in the places where they live may affect their bodies over time. Researchers need better ways to study these effects. 

The FARSC study will involve collecting samples of blood, hair, fingernails, and saliva (spit) from survivors and siblings. The study will look at whether families can collect samples and do study tasks at home. It will also see how families feel about these tasks. 

Survivors and siblings will answer questions and wear a device that tracks sleep. They will collect saliva samples at home for 3 days. If possible, these will be 3 days in a row. Caregivers will also answer questions.  

What we learn from this study may help researchers plan a larger study about the long-term health of children and teens who had ALL.

Eligibility overview 

  • 8–18 years old 
  • Cancer-free 
  • Followed in the St. Jude After Completion of Care (ACT) Clinic  
  • Diagnosed with acute lymphoblastic leukemia at least 5 years ago and completed treatment at least 2 years ago  
  • Received treatment on the St. Jude TOT16 or TOT17 clinical trial  
  • Did not receive radiation to the head 
  • Has internet access  

Survivors do not need a sibling to enroll. A sibling may take part only if the survivor enrolls.


The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.

Overview

Full title:

FARSC: Feasibility and Acceptability of Remote Saliva Collection

Study goal:

To learn whether families can collect samples and complete study activities at home

Diagnosis:

Acute lymphoblastic leukemia (ALL) 

Age:

8–18 years old

Clinical trial categories:

Acute Lymphoblastic Leukemia (ALL)

For physicians and researchers

Patients accepted to St. Jude must be referred by a physician or other qualified medical professional. Learn how St. Jude can partner with you to care for your patient.

 

Learn more